✦ LIBER ✦

HER2-Positive Breast Cancer: From Trastuzumab to Innovatory Anti-HER2 Strategies

✍ Scribed by Nicolas Whenham; Véronique D'Hondt; Martine J. Piccart

Book ID: 115075770
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 352 KB
Volume: 8
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2008.n.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant trastuzumab for HER2-positive b

Adjuvant trastuzumab for HER2-positive breast cancer

✍ James Spicer; Mark Harries; Paul Ellis 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 47 KB

Adjuvant Trastuzumab in HER2-Positive Br

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

✍ Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Marti 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 713 KB

Adjuvant Trastuzumab Therapy for HER2-Po

Adjuvant Trastuzumab Therapy for HER2-Positive Breast Cancer

✍ Mohammad Jahanzeb 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 148 KB

Duration of trastuzumab for HER2-positiv

Duration of trastuzumab for HER2-positive breast cancer

✍ Montemurro, Filippo; Aglietta, Massimo 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 203 KB

Trastuzumab cost effective in HER2-posit

Trastuzumab cost effective in HER2-positive breast cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 125 KB

Neoadjuvant trastuzumab + FEC for HER2-p

Neoadjuvant trastuzumab + FEC for HER2-positive breast cancer

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB